25 XP   0   0   10

Valneva SE ADR
Buy, Hold or Sell?

Let's analyse Valneva together

PenkeI guess you are interested in Valneva SE ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Valneva SE ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Valneva SE ADR

I send you an email if I find something interesting about Valneva SE ADR.

Quick analysis of Valneva (30 sec.)










What can you expect buying and holding a share of Valneva? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$0.98
Expected worth in 1 year
$0.39
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.59
Return On Investment
-7.3%

For what price can you sell your share?

Current Price per Share
$8.13
Expected price per share
$6.58 - $9.7684
How sure are you?
50%

1. Valuation of Valneva (5 min.)




Live pricePrice per Share (EOD)

$8.13

Intrinsic Value Per Share

$-63.43 - $-12.14

Total Value Per Share

$-62.45 - $-11.15

2. Growth of Valneva (5 min.)




Is Valneva growing?

Current yearPrevious yearGrowGrow %
How rich?$136.5m$168.6m$12.6m7.0%

How much money is Valneva making?

Current yearPrevious yearGrowGrow %
Making money-$26.9m$587.9k-$27.5m-102.2%
Net Profit Margin-65.7%-61.6%--

How much money comes from the company's main activities?

3. Financial Health of Valneva (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#325 / 1016

Most Revenue
#172 / 1016

Most Profit
#759 / 1016

Most Efficient
#552 / 1016

What can you expect buying and holding a share of Valneva? (5 min.)

Welcome investor! Valneva's management wants to use your money to grow the business. In return you get a share of Valneva.

What can you expect buying and holding a share of Valneva?

First you should know what it really means to hold a share of Valneva. And how you can make/lose money.

Speculation

The Price per Share of Valneva is $8.1299. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Valneva.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Valneva, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.98. Based on the TTM, the Book Value Change Per Share is $-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Valneva.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.25-3.0%-0.22-2.8%-0.31-3.8%-0.28-3.4%-0.18-2.2%
Usd Book Value Change Per Share-0.22-2.8%-0.15-1.8%-0.08-0.9%-0.03-0.4%-0.03-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Total Gains Per Share-0.22-2.8%-0.15-1.8%-0.07-0.9%-0.03-0.4%-0.02-0.3%
Usd Price Per Share10.37-11.74-19.96-12.00-6.00-
Price to Earnings Ratio-10.51--14.97--11.59-3.63-1.82-
Price-to-Total Gains Ratio-46.18--23.47--28.86--58.59--58.59-
Price to Book Ratio10.54-8.37-13.02-9.31-4.66-
Price-to-Total Gains Ratio-46.18--23.47--28.86--58.59--58.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.1299
Number of shares123
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.15-0.03
Usd Total Gains Per Share-0.15-0.03
Gains per Quarter (123 shares)-18.20-3.89
Gains per Year (123 shares)-72.82-15.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-73-831-16-26
20-146-1561-32-42
31-219-2292-48-58
41-292-3022-64-74
51-365-3753-80-90
61-438-4483-96-106
71-511-5214-113-122
81-584-5944-129-138
92-657-6675-145-154
102-730-7405-161-170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%7.033.00.017.5%7.039.00.015.2%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%15.025.00.037.5%18.027.01.039.1%
Dividend per Share1.00.03.025.0%3.00.09.025.0%4.00.016.020.0%5.00.035.012.5%6.00.040.013.0%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%15.025.00.037.5%19.026.01.041.3%

Fundamentals of Valneva

About Valneva SE ADR

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.

Fundamental data was last updated by Penke on 2024-04-12 21:15:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Valneva SE ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Valneva earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Net Profit Margin of -76.8% means that $-0.77 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Valneva SE ADR:

  • The MRQ is -76.8%. The company is making a huge loss. -2
  • The TTM is -65.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-76.8%TTM-65.7%-11.1%
TTM-65.7%YOY-61.6%-4.1%
TTM-65.7%5Y-103.9%+38.2%
5Y-103.9%10Y-68.1%-35.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.8%-197.2%+120.4%
TTM-65.7%-210.4%+144.7%
YOY-61.6%-279.3%+217.7%
5Y-103.9%-436.8%+332.9%
10Y-68.1%-599.3%+531.2%
1.1.2. Return on Assets

Shows how efficient Valneva is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • -6.9% Return on Assets means that Valneva generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Valneva SE ADR:

  • The MRQ is -6.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.9%TTM-4.9%-1.9%
TTM-4.9%YOY0.1%-5.0%
TTM-4.9%5Y-2.4%-2.5%
5Y-2.4%10Y-2.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.9%-13.6%+6.7%
TTM-4.9%-12.9%+8.0%
YOY0.1%-11.9%+12.0%
5Y-2.4%-14.2%+11.8%
10Y-2.4%-16.2%+13.8%
1.1.3. Return on Equity

Shows how efficient Valneva is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • -25.1% Return on Equity means Valneva generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Valneva SE ADR:

  • The MRQ is -25.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.1%TTM-16.1%-8.9%
TTM-16.1%YOY-2.0%-14.1%
TTM-16.1%5Y-19.1%+3.0%
5Y-19.1%10Y-11.9%-7.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.1%-17.0%-8.1%
TTM-16.1%-16.1%0.0%
YOY-2.0%-15.4%+13.4%
5Y-19.1%-20.0%+0.9%
10Y-11.9%-21.1%+9.2%

1.2. Operating Efficiency of Valneva SE ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Valneva is operating .

  • Measures how much profit Valneva makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • An Operating Margin of -70.2% means the company generated $-0.70  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Valneva SE ADR:

  • The MRQ is -70.2%. The company is operating very inefficient. -2
  • The TTM is -55.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-70.2%TTM-55.9%-14.3%
TTM-55.9%YOY-39.6%-16.3%
TTM-55.9%5Y-91.1%+35.2%
5Y-91.1%10Y-53.6%-37.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-70.2%-286.1%+215.9%
TTM-55.9%-224.4%+168.5%
YOY-39.6%-288.4%+248.8%
5Y-91.1%-475.2%+384.1%
10Y-53.6%-624.7%+571.1%
1.2.2. Operating Ratio

Measures how efficient Valneva is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are $1.70 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Valneva SE ADR:

  • The MRQ is 1.702. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.559. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.702TTM1.559+0.143
TTM1.559YOY1.396+0.163
TTM1.5595Y1.919-0.360
5Y1.91910Y1.596+0.323
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7022.997-1.295
TTM1.5593.247-1.688
YOY1.3963.766-2.370
5Y1.9195.675-3.756
10Y1.5967.857-6.261

1.3. Liquidity of Valneva SE ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Valneva is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.65 means the company has $1.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Valneva SE ADR:

  • The MRQ is 1.654. The company is able to pay all its short-term debts. +1
  • The TTM is 1.505. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.654TTM1.505+0.149
TTM1.505YOY1.352+0.153
TTM1.5055Y2.011-0.506
5Y2.01110Y2.189-0.179
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6543.930-2.276
TTM1.5054.251-2.746
YOY1.3525.436-4.084
5Y2.0116.045-4.034
10Y2.1896.363-4.174
1.3.2. Quick Ratio

Measures if Valneva is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Quick Ratio of 1.06 means the company can pay off $1.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Valneva SE ADR:

  • The MRQ is 1.056. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.784. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.056TTM0.784+0.272
TTM0.784YOY0.700+0.084
TTM0.7845Y1.256-0.473
5Y1.25610Y1.375-0.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0563.629-2.573
TTM0.7844.065-3.281
YOY0.7005.397-4.697
5Y1.2565.993-4.737
10Y1.3756.277-4.902

1.4. Solvency of Valneva SE ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Valneva assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Valneva to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.73 means that Valneva assets are financed with 72.7% credit (debt) and the remaining percentage (100% - 72.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Valneva SE ADR:

  • The MRQ is 0.727. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.681. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.727TTM0.681+0.045
TTM0.681YOY0.770-0.088
TTM0.6815Y0.703-0.021
5Y0.70310Y0.587+0.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7270.332+0.395
TTM0.6810.334+0.347
YOY0.7700.268+0.502
5Y0.7030.366+0.337
10Y0.5870.390+0.197
1.4.2. Debt to Equity Ratio

Measures if Valneva is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Debt to Equity ratio of 266.0% means that company has $2.66 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Valneva SE ADR:

  • The MRQ is 2.660. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.173. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.660TTM2.173+0.487
TTM2.173YOY3.920-1.747
TTM2.1735Y3.611-1.438
5Y3.61110Y2.257+1.354
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6600.381+2.279
TTM2.1730.390+1.783
YOY3.9200.334+3.586
5Y3.6110.434+3.177
10Y2.2570.466+1.791

2. Market Valuation of Valneva SE ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Valneva generates.

  • Above 15 is considered overpriced but always compare Valneva to the Biotechnology industry mean.
  • A PE ratio of -10.51 means the investor is paying $-10.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Valneva SE ADR:

  • The EOD is -8.240. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.509. Based on the earnings, the company is expensive. -2
  • The TTM is -14.966. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.240MRQ-10.509+2.269
MRQ-10.509TTM-14.966+4.457
TTM-14.966YOY-11.593-3.373
TTM-14.9665Y3.632-18.599
5Y3.63210Y1.816+1.816
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.240-2.315-5.925
MRQ-10.509-2.560-7.949
TTM-14.966-2.664-12.302
YOY-11.593-4.122-7.471
5Y3.632-6.258+9.890
10Y1.816-6.108+7.924
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Valneva SE ADR:

  • The EOD is -3.526. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.497. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.617. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.526MRQ-4.497+0.971
MRQ-4.497TTM-6.617+2.120
TTM-6.617YOY-12.155+5.538
TTM-6.6175Y1.627-8.244
5Y1.62710Y0.814+0.814
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.526-3.067-0.459
MRQ-4.497-3.251-1.246
TTM-6.617-3.545-3.072
YOY-12.155-5.595-6.560
5Y1.627-8.315+9.942
10Y0.814-8.708+9.522
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Valneva is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.54 means the investor is paying $10.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Valneva SE ADR:

  • The EOD is 8.264. Based on the equity, the company is overpriced. -1
  • The MRQ is 10.540. Based on the equity, the company is expensive. -2
  • The TTM is 8.371. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.264MRQ10.540-2.276
MRQ10.540TTM8.371+2.169
TTM8.371YOY13.019-4.648
TTM8.3715Y9.311-0.940
5Y9.31110Y4.655+4.655
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.2641.905+6.359
MRQ10.5402.111+8.429
TTM8.3712.095+6.276
YOY13.0192.836+10.183
5Y9.3113.443+5.868
10Y4.6553.794+0.861
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Valneva SE ADR.

3.1. Institutions holding Valneva SE ADR

Institutions are holding 0.607% of the shares of Valneva SE ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31General American Investors Company Inc0.49720.28134500000
2023-12-31AlphaCentric Advisors, LLC0.04940.2369342981370866.576
2023-09-30LAURION CAPITAL MANAGEMENT LP0.0360.00182500000
2023-12-31Morgan Stanley - Brokerage Accounts0.00630436050012.9534
2023-12-31Wells Fargo & Co0.00360252000
2023-12-31Barclays PLC0.000604174170
2023-12-31Advisor Group Holdings, Inc.0.0002015000
2023-12-31Qube Research & Technologies002200
2023-12-31Royal Bank of Canada002000
2023-09-30Ridgewood Investments LLC000-550-100
2023-12-31JPMorgan Chase & Co000-39-100
2023-09-30UBS Group AG000-2-100
Total 0.59330.5197411787+14034+3.4%

3.2. Funds holding Valneva SE ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30General American Investors0.49720.42234500000
2023-12-31AlphaCentric LifeSci Healthcare I0.04940.3386342981370866.576
2024-02-29Fidelity Nasdaq Composite Index0.0005035900
Total 0.54710.7606379657+13708+3.6%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Valneva SE ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.225-0.148-34%-0.076-66%-0.033-85%-0.031-86%
Book Value Per Share--0.9841.696-42%1.692-42%1.437-32%1.562-37%
Current Ratio--1.6541.505+10%1.352+22%2.011-18%2.189-24%
Debt To Asset Ratio--0.7270.681+7%0.770-6%0.703+3%0.587+24%
Debt To Equity Ratio--2.6602.173+22%3.920-32%3.611-26%2.257+18%
Dividend Per Share---0.000-100%0.001-100%0.001-100%0.006-100%
Eps---0.247-0.224-9%-0.307+25%-0.278+13%-0.177-28%
Free Cash Flow Per Share---0.576-0.476-17%-0.523-9%-0.120-79%-0.070-88%
Free Cash Flow To Equity Per Share---0.264-0.355+35%-0.483+83%0.005-5086%0.014-1981%
Gross Profit Margin--1.4611.504-3%1.145+28%9.341-84%5.428-73%
Intrinsic Value_10Y_max---12.136--------
Intrinsic Value_10Y_min---63.435--------
Intrinsic Value_1Y_max---0.417--------
Intrinsic Value_1Y_min---2.229--------
Intrinsic Value_3Y_max---1.862--------
Intrinsic Value_3Y_min---10.311--------
Intrinsic Value_5Y_max---4.041--------
Intrinsic Value_5Y_min---22.293--------
Market Cap564165500.130-155%1439090905.5801451941769.858-1%1918025451.815-25%1233809454.193+17%616904727.096+133%
Net Profit Margin---0.768-0.657-14%-0.616-20%-1.039+35%-0.681-11%
Operating Margin---0.702-0.559-20%-0.396-44%-0.911+30%-0.536-24%
Operating Ratio--1.7021.559+9%1.396+22%1.919-11%1.596+7%
Pb Ratio8.264-28%10.5408.371+26%13.019-19%9.311+13%4.655+126%
Pe Ratio-8.240+22%-10.509-14.966+42%-11.593+10%3.632-389%1.816-679%
Price Per Share8.130-28%10.36911.737-12%19.956-48%12.002-14%6.001+73%
Price To Free Cash Flow Ratio-3.526+22%-4.497-6.617+47%-12.155+170%1.627-376%0.814-653%
Price To Total Gains Ratio-36.205+22%-46.176-23.474-49%-28.859-38%-58.590+27%-58.590+27%
Quick Ratio--1.0560.784+35%0.700+51%1.256-16%1.375-23%
Return On Assets---0.069-0.049-28%0.001-5329%-0.024-65%-0.024-65%
Return On Equity---0.251-0.161-36%-0.020-92%-0.191-24%-0.119-53%
Total Gains Per Share---0.225-0.148-34%-0.075-67%-0.032-86%-0.025-89%
Usd Book Value--136531756.200181316816.700-25%168633172.300-19%139888173.850-2%133451682.095+2%
Usd Book Value Change Per Share---0.225-0.148-34%-0.076-66%-0.033-85%-0.031-86%
Usd Book Value Per Share--0.9841.696-42%1.692-42%1.437-32%1.562-37%
Usd Dividend Per Share---0.000-100%0.001-100%0.001-100%0.006-100%
Usd Eps---0.247-0.224-9%-0.307+25%-0.278+13%-0.177-28%
Usd Free Cash Flow---80002560.800-58652540.100-27%-52314976.300-35%-17049249.620-79%-9090300.020-89%
Usd Free Cash Flow Per Share---0.576-0.476-17%-0.523-9%-0.120-79%-0.070-88%
Usd Free Cash Flow To Equity Per Share---0.264-0.355+35%-0.483+83%0.005-5086%0.014-1981%
Usd Market Cap564165500.130-155%1439090905.5801451941769.858-1%1918025451.815-25%1233809454.193+17%616904727.096+133%
Usd Price Per Share8.130-28%10.36911.737-12%19.956-48%12.002-14%6.001+73%
Usd Profit---34235406.800-26995328.350-21%587925.350-5923%-12710365.860-63%-9130834.665-73%
Usd Revenue--44605675.40040910714.950+9%62247694.300-28%51750046.310-14%37257433.590+20%
Usd Total Gains Per Share---0.225-0.148-34%-0.075-67%-0.032-86%-0.025-89%
 EOD+3 -5MRQTTM+6 -30YOY+11 -255Y+12 -2410Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Valneva SE ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.240
Price to Book Ratio (EOD)Between0-18.264
Net Profit Margin (MRQ)Greater than0-0.768
Operating Margin (MRQ)Greater than0-0.702
Quick Ratio (MRQ)Greater than11.056
Current Ratio (MRQ)Greater than11.654
Debt to Asset Ratio (MRQ)Less than10.727
Debt to Equity Ratio (MRQ)Less than12.660
Return on Equity (MRQ)Greater than0.15-0.251
Return on Assets (MRQ)Greater than0.05-0.069
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Valneva SE ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.599
Ma 20Greater thanMa 508.076
Ma 50Greater thanMa 1007.714
Ma 100Greater thanMa 2008.842
OpenGreater thanClose7.760
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets469,391
Total Liabilities341,144
Total Stockholder Equity128,247
 As reported
Total Liabilities 341,144
Total Stockholder Equity+ 128,247
Total Assets = 469,391

Assets

Total Assets469,391
Total Current Assets262,824
Long-term Assets206,567
Total Current Assets
Cash And Cash Equivalents 126,080
Net Receivables 41,645
Inventory 44,466
Other Current Assets 50,633
Total Current Assets  (as reported)262,824
Total Current Assets  (calculated)262,824
+/-0
Long-term Assets
Property Plant Equipment 156,590
Intangible Assets 25,567
Long-term Assets Other 8,489
Long-term Assets  (as reported)206,567
Long-term Assets  (calculated)190,646
+/- 15,921

Liabilities & Shareholders' Equity

Total Current Liabilities158,863
Long-term Liabilities182,281
Total Stockholder Equity128,247
Total Current Liabilities
Short-term Debt 46,958
Short Long Term Debt 44,079
Accounts payable 17,564
Other Current Liabilities 88,644
Total Current Liabilities  (as reported)158,863
Total Current Liabilities  (calculated)197,245
+/- 38,382
Long-term Liabilities
Long term Debt 132,768
Capital Lease Obligations 31,969
Long-term Liabilities Other 79
Long-term Liabilities  (as reported)182,281
Long-term Liabilities  (calculated)164,816
+/- 17,465
Total Stockholder Equity
Common Stock20,837
Retained Earnings -551,682
Accumulated Other Comprehensive Income 65,734
Other Stockholders Equity 593,358
Total Stockholder Equity (as reported)128,247
Total Stockholder Equity (calculated)128,247
+/-0
Other
Capital Stock20,837
Cash and Short Term Investments 126,080
Common Stock Shares Outstanding 138,788
Current Deferred Revenue5,697
Liabilities and Stockholders Equity 469,391
Net Debt 82,736
Net Invested Capital 305,094
Net Working Capital 103,960
Property Plant and Equipment Gross 156,590
Short Long Term Debt Total 208,816



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-06-302010-12-312010-06-302009-12-31
> Total Assets 
45,954
54,807
79,499
79,352
73,083
60,444
60,444
53,667
53,667
245,274
241,902
254,391
241,294
243,388
240,398
227,517
290,633
283,082
274,311
275,187
247,349
209,785
202,962
206,883
198,568
198,200
191,730
189,343
186,506
181,475
175,338
229,907
243,742
249,143
250,649
264,723
276,574
389,349
450,185
449,164
574,112
745,107
745,107
817,352
817,352
725,105
698,083
590,000
590,000
542,571
520,539
469,391
469,391520,539542,571590,000590,000698,083725,105817,352817,352745,107745,107574,112449,164450,185389,349276,574264,723250,649249,143243,742229,907175,338181,475186,506189,343191,730198,200198,568206,883202,962209,785247,349275,187274,311283,082290,633227,517240,398243,388241,294254,391241,902245,27453,66753,66760,44460,44473,08379,35279,49954,80745,954
   > Total Current Assets 
29,775
25,389
46,887
40,018
33,455
22,017
0
15,220
0
53,976
52,062
63,346
51,963
59,825
59,172
60,948
103,184
98,950
94,191
116,382
91,146
92,020
87,055
91,198
84,328
87,251
86,240
83,448
81,479
79,523
74,009
125,973
117,483
121,861
118,933
129,162
142,691
253,446
311,272
308,427
416,981
561,962
585,832
585,833
545,021
503,776
476,535
389,329
389,329
341,480
320,653
262,824
262,824320,653341,480389,329389,329476,535503,776545,021585,833585,832561,962416,981308,427311,272253,446142,691129,162118,933121,861117,483125,97374,00979,52381,47983,44886,24087,25184,32891,19887,05592,02091,146116,38294,19198,950103,18460,94859,17259,82551,96363,34652,06253,976015,220022,01733,45540,01846,88725,38929,775
       Cash And Cash Equivalents 
23,563
8,154
34,748
30,420
9,907
122
0
832
0
15,591
18,179
36,509
27,706
31,261
30,269
28,857
38,979
43,673
37,258
41,907
33,408
38,656
40,293
35,268
45,208
43,907
40,560
33,545
36,172
34,635
33,040
77,085
68,059
69,945
67,387
64,439
80,832
200,046
156,178
204,394
235,913
329,723
0
346,642
0
336,177
261,042
254,485
254,485
204,411
171,253
126,080
126,080171,253204,411254,485254,485261,042336,1770346,6420329,723235,913204,394156,178200,04680,83264,43967,38769,94568,05977,08533,04034,63536,17233,54540,56043,90745,20835,26840,29338,65633,40841,90737,25843,67338,97928,85730,26931,26127,70636,50918,17915,591083201229,90730,42034,7488,15423,563
       Short-term Investments 
0
0
7,755
5,750
20,648
17,852
0
11,225
0
7,517
0
3,658
1,000
6,000
6,650
19
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003200000000000000196,6506,0001,0003,65807,517011,225017,85220,6485,7507,75500
       Net Receivables 
0
4,502
0
290
881
1,835
0
1,684
0
14,449
18,101
7,569
6,081
3,844
2,156
6,850
20,384
12,274
15,386
15,754
22,803
21,655
12,946
16,912
11,864
13,109
13,182
17,622
18,249
15,892
8,247
11,259
15,056
14,086
9,898
24,030
16,736
7,524
109,203
19,231
25,100
18,007
44,013
44,013
25,061
16,251
57,732
27,018
27,018
33,668
44,346
41,645
41,64544,34633,66827,01827,01857,73216,25125,06144,01344,01318,00725,10019,231109,2037,52416,73624,0309,89814,08615,05611,2598,24715,89218,24917,62213,18213,10911,86416,91212,94621,65522,80315,75415,38612,27420,3846,8502,1563,8446,0817,56918,10114,44901,68401,83588129004,5020
       Other Current Assets 
5,561
12,124
3,904
2,821
1,068
1,306
0
283
0
8,068
9,104
10,791
10,805
9,525
11,098
9,366
13,507
11,883
12,227
31,374
13,025
7,696
9,062
9,404
7,110
9,426
9,058
7,840
7,801
8,790
9,705
10,261
11,121
13,241
14,662
14,921
17,006
15,382
17,497
57,828
58,568
88,526
71,035
71,036
68,971
53,965
59,165
66,693
66,693
65,082
67,054
50,633
50,63367,05465,08266,69366,69359,16553,96568,97171,03671,03588,52658,56857,82817,49715,38217,00614,92114,66213,24111,12110,2619,7058,7907,8017,8409,0589,4267,1109,4049,0627,69613,02531,37412,22711,88313,5079,36611,0989,52510,80510,7919,1048,068028301,3061,0682,8213,90412,1245,561
   > Long-term Assets 
16,179
29,418
32,612
39,334
39,628
38,427
0
38,446
0
191,298
189,840
191,045
189,330
183,564
181,225
166,567
187,449
184,132
180,120
158,804
156,203
117,763
115,908
115,686
114,240
110,949
105,491
105,895
105,027
101,951
101,329
103,934
126,259
127,283
131,717
135,561
133,883
135,902
138,912
140,737
157,132
183,145
0
231,520
0
221,330
221,548
200,671
200,671
201,091
199,885
206,567
206,567199,885201,091200,671200,671221,548221,3300231,5200183,145157,132140,737138,912135,902133,883135,561131,717127,283126,259103,934101,329101,951105,027105,895105,491110,949114,240115,686115,908117,763156,203158,804180,120184,132187,449166,567181,225183,564189,330191,045189,840191,298038,446038,42739,62839,33432,61229,41816,179
       Property Plant Equipment 
8,726
12,486
13,085
13,030
13,315
12,754
0
12,094
0
46,395
45,715
45,069
44,221
43,686
43,180
41,611
52,266
51,693
50,697
42,440
40,810
40,177
39,682
39,040
38,702
38,654
38,303
38,373
38,082
37,558
37,327
37,997
62,362
63,779
66,517
69,336
66,644
67,647
71,728
78,154
93,622
123,028
173,830
173,831
175,980
169,992
170,659
158,039
158,039
156,100
156,133
156,590
156,590156,133156,100158,039158,039170,659169,992175,980173,831173,830123,02893,62278,15471,72867,64766,64469,33666,51763,77962,36237,99737,32737,55838,08238,37338,30338,65438,70239,04039,68240,17740,81042,44050,69751,69352,26641,61143,18043,68644,22145,06945,71546,395012,094012,75413,31513,03013,08512,4868,726
       Goodwill 
0
9,760
0
341
0
0
0
341
0
0
0
350
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000035000034100034109,7600
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,130
0
0
0
2,124
0
0
0
0
0
0
0
0
000000002,1240002,130000000000000000000000000000000000000000
       Intangible Assets 
0
5,034
15,499
20,499
0
0
0
17,030
0
0
0
125,051
0
121,139
118,742
105,204
105,986
105,918
103,726
98,566
97,146
61,092
59,177
58,959
57,421
55,850
50,382
48,468
47,561
46,613
0
44,891
0
0
0
41,812
0
0
0
35,410
0
0
0
32,700
0
30,714
29,652
27,896
0
27,125
26,341
25,567
25,56726,34127,125027,89629,65230,714032,70000035,41000041,81200044,891046,61347,56148,46850,38255,85057,42158,95959,17761,09297,14698,566103,726105,918105,986105,204118,742121,1390125,05100017,03000020,49915,4995,0340
       Long-term Assets Other 
2,274
2,138
4,028
5,144
5,957
7,182
0
-3
0
18,709
19,256
20,575
20,898
18,739
19,303
19,752
29,197
26,521
25,697
17,798
18,247
16,494
17,049
17,687
18,117
16,445
16,806
17,368
17,835
16,337
16,850
17,235
17,634
16,204
16,578
17,162
17,505
18,921
19,386
19,473
19,853
18,063
0
19,283
0
17,948
18,294
8,590
8,590
7,932
8,222
8,489
8,4898,2227,9328,5908,59018,29417,948019,283018,06319,85319,47319,38618,92117,50517,16216,57816,20417,63417,23516,85016,33717,83517,36816,80616,44518,11717,68717,04916,49418,24717,79825,69726,52129,19719,75219,30318,73920,89820,57519,25618,7090-307,1825,9575,1444,0282,1382,274
> Total Liabilities 
23,425
38,039
35,211
37,623
32,638
27,225
0
27,473
0
124,065
90,949
110,280
104,072
102,479
103,487
103,073
132,193
132,115
129,103
130,852
107,584
105,517
105,385
106,832
99,106
100,059
95,520
96,674
91,782
89,533
85,611
86,721
104,554
117,419
119,021
129,570
143,417
278,290
373,457
371,742
521,757
668,037
0
646,771
0
631,850
533,100
385,217
385,217
351,864
363,018
341,144
341,144363,018351,864385,217385,217533,100631,8500646,7710668,037521,757371,742373,457278,290143,417129,570119,021117,419104,55486,72185,61189,53391,78296,67495,520100,05999,106106,832105,385105,517107,584130,852129,103132,115132,193103,073103,487102,479104,072110,28090,949124,065027,473027,22532,63837,62335,21138,03923,425
   > Total Current Liabilities 
6,999
12,958
12,924
16,160
13,339
11,350
0
9,808
0
58,956
28,949
28,099
22,883
24,622
25,522
27,369
35,113
39,302
39,762
46,362
30,072
33,710
35,877
38,889
35,556
40,141
38,061
37,674
45,993
46,193
41,264
42,945
27,633
39,849
31,547
41,299
45,133
104,723
201,936
175,872
320,356
456,917
368,979
368,979
363,257
436,128
374,212
263,259
263,259
241,042
218,150
158,863
158,863218,150241,042263,259263,259374,212436,128363,257368,979368,979456,917320,356175,872201,936104,72345,13341,29931,54739,84927,63342,94541,26446,19345,99337,67438,06140,14135,55638,88935,87733,71030,07246,36239,76239,30235,11327,36925,52224,62222,88328,09928,94958,95609,808011,35013,33916,16012,92412,9586,999
       Short-term Debt 
1,024
1,185
1,257
1,442
1,528
1,608
0
1,641
0
32,640
6,859
6,380
7,258
6,957
6,894
7,118
4,795
5,868
7,175
25,687
12,439
15,650
17,338
20,958
17,821
19,933
17,937
17,399
25,360
22,957
20,032
17,530
4,217
3,695
3,752
4,307
8,442
10,224
10,049
9,684
8,548
10,168
0
10,242
0
14,532
15,612
39,944
0
47,134
59,605
46,958
46,95859,60547,134039,94415,61214,532010,242010,1688,5489,68410,04910,2248,4424,3073,7523,6954,21717,53020,03222,95725,36017,39917,93719,93317,82120,95817,33815,65012,43925,6877,1755,8684,7957,1186,8946,9577,2586,3806,85932,64001,64101,6081,5281,4421,2571,1851,024
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,181
7,823
7,597
6,988
5,944
7,079
0
7,107
0
11,543
12,494
11,580
14,157
21,195
33,811
44,079
44,07933,81121,19514,15711,58012,49411,54307,10707,0795,9446,9887,5977,8236,181000000000000000000000000000000000000
       Accounts payable 
984
1,617
867
1,097
3,201
1,505
0
745
0
16,402
10,948
6,487
7,588
9,101
8,277
5,192
14,104
14,271
12,840
6,325
9,304
10,062
10,341
7,808
8,934
9,862
9,406
5,258
9,480
11,353
9,189
9,175
10,113
14,994
13,246
8,868
17,491
19,778
13,968
24,898
60,878
71,502
16,035
16,035
66,268
83,704
74,973
33,520
33,520
69,152
94,241
17,564
17,56494,24169,15233,52033,52074,97383,70466,26816,03516,03571,50260,87824,89813,96819,77817,4918,86813,24614,99410,1139,1759,18911,3539,4805,2589,4069,8628,9347,80810,34110,0629,3046,32512,84014,27114,1045,1928,2779,1017,5886,48710,94816,402074501,5053,2011,0978671,617984
       Other Current Liabilities 
3,707
8,090
9,304
12,122
8,610
6,621
0
5,966
0
5,541
5,632
5,235
4,720
4,430
4,655
3,844
9,901
12,784
12,795
2,664
2,243
1,772
1,819
2,439
2,474
2,851
3,222
2,896
2,919
2,927
12,043
2,041
13,303
9,000
14,549
26,982
2,873
4,087
15,232
51,712
45,974
36,773
273,369
218,685
262,299
218,181
276,721
180,636
140,304
113,176
50,961
88,644
88,64450,961113,176140,304180,636276,721218,181262,299218,685273,36936,77345,97451,71215,2324,0872,87326,98214,5499,00013,3032,04112,0432,9272,9192,8963,2222,8512,4742,4391,8191,7722,2432,66412,79512,7849,9013,8444,6554,4304,7205,2355,6325,54105,96606,6218,61012,1229,3048,0903,707
   > Long-term Liabilities 
16,426
25,081
22,287
21,463
19,299
15,875
0
17,665
0
65,109
62,000
82,181
81,189
77,857
77,965
75,704
97,080
92,813
89,341
84,490
77,512
71,807
69,508
67,943
63,550
59,918
57,459
59,000
45,789
43,340
44,347
43,776
76,921
77,570
87,474
88,271
98,284
173,567
171,521
195,870
201,401
211,120
0
277,792
0
195,722
158,888
121,958
121,958
110,822
144,868
182,281
182,281144,868110,822121,958121,958158,888195,7220277,7920211,120201,401195,870171,521173,56798,28488,27187,47477,57076,92143,77644,34743,34045,78959,00057,45959,91863,55067,94369,50871,80777,51284,49089,34192,81397,08075,70477,96577,85781,18982,18162,00065,109017,665015,87519,29921,46322,28725,08116,426
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,839
70,302
100,105
103,939
109,802
173,379
173,379
165,380
76,733
12,882
0
0
8,723
9,969
0
09,9698,7230012,88276,733165,380173,379173,379109,802103,939100,10570,30270,8390000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,738
0
0
1,581
1,581
0
0
0
1,394
0
0
0
0
00001,3940001,5811,581001,738000000000000000000000000000000000000000
> Total Stockholder Equity
22,529
16,768
44,288
41,729
40,445
33,219
0
26,194
0
121,209
150,953
144,111
137,222
140,909
136,911
124,444
158,440
150,967
145,208
144,335
139,765
104,268
97,577
100,051
99,462
98,141
96,210
92,669
94,724
91,942
89,727
143,186
139,188
131,724
131,628
135,153
133,157
111,059
76,728
77,422
52,355
77,070
0
170,581
0
93,255
164,983
204,783
204,783
190,707
157,521
128,247
128,247157,521190,707204,783204,783164,98393,2550170,581077,07052,35577,42276,728111,059133,157135,153131,628131,724139,188143,18689,72791,94294,72492,66996,21098,14199,462100,05197,577104,268139,765144,335145,208150,967158,440124,444136,911140,909137,222144,111150,953121,209026,194033,21940,44541,72944,28816,76822,529
   Common Stock
2,220
2,223
3,149
3,151
3,168
3,182
0
3,219
0
6,093
8,375
8,206
8,212
8,452
8,452
8,453
11,199
11,199
11,205
11,205
11,205
11,205
11,205
11,638
11,638
11,638
11,638
11,638
11,638
11,638
11,638
13,638
13,638
13,638
13,641
13,642
13,642
13,642
13,643
13,646
13,765
14,986
15,786
15,786
16,170
17,603
17,603
20,752
0
20,834
20,837
20,837
20,83720,83720,834020,75217,60317,60316,17015,78615,78614,98613,76513,64613,64313,64213,64213,64213,64113,63813,63813,63811,63811,63811,63811,63811,63811,63811,63811,63811,20511,20511,20511,20511,20511,19911,1998,4538,4528,4528,2128,2068,3756,09303,21903,1823,1683,1513,1492,2232,220
   Retained Earnings -551,682-519,524-485,299-468,380-468,380-406,049-478,467-333,015-306,974-316,491-319,948-261,251-233,549-234,681-200,322-178,217-176,220-179,738-179,642-172,169-168,171-174,845-172,630-169,848-171,903-168,362-166,431-165,110-164,523-159,594-152,902-117,405-112,836-111,962-106,030-98,558-90,716-78,249-74,239-69,306-62,418-56,336-47,4050-39,4390-32,105-24,839-23,555-20,515-19,190-13,141
   Capital Surplus 0000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
33,450
33,735
61,654
67,519
68,328
69,063
0
70,235
0
162,521
198,914
225,752
198,316
206,696
206,708
237,758
245,799
245,798
245,965
280,409
245,965
245,965
245,966
288,678
252,934
252,934
252,934
287,207
252,934
252,934
252,934
334,734
297,719
297,728
297,725
328,894
297,732
297,739
297,766
330,481
247,073
382,032
62,673
409,257
52,452
501,637
501,638
594,042
0
593,961
594,003
593,358
593,358594,003593,9610594,042501,638501,63752,452409,25762,673382,032247,073330,481297,766297,739297,732328,894297,725297,728297,719334,734252,934252,934252,934287,207252,934252,934252,934288,678245,966245,965245,965280,409245,965245,798245,799237,758206,708206,696198,316225,752198,914162,521070,235069,06368,32867,51961,65433,73533,450



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue153,713
Cost of Revenue-105,175
Gross Profit48,53848,538
 
Operating Income (+$)
Gross Profit48,538
Operating Expense-152,620
Operating Income-104,082-104,082
 
Operating Expense (+$)
Research Development56,894
Selling General Administrative47,799
Selling And Marketing Expenses48,752
Operating Expense152,620153,445
 
Net Interest Income (+$)
Interest Income925
Interest Expense-23,325
Other Finance Cost-5,189
Net Interest Income-17,211
 
Pretax Income (+$)
Operating Income-104,082
Net Interest Income-17,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-105,426-102,738
EBIT - interestExpense = -127,407
-105,426
-78,104
Interest Expense23,325
Earnings Before Interest and Taxes (EBIT)-104,082-82,101
Earnings Before Interest and Taxes (EBITDA)-86,498
 
After tax Income (+$)
Income Before Tax-105,426
Tax Provision--4,802
Net Income From Continuing Ops-113,475-100,624
Net Income-101,429
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses257,795
Total Other Income/Expenses Net-1,34417,211
 

Technical Analysis of Valneva
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Valneva. The general trend of Valneva is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Valneva's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Valneva SE ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.8899 < 9.07 < 9.7684.

The bearish price targets are: 7.1 > 6.58.

Tweet this
Valneva SE ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Valneva SE ADR. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Valneva SE ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Valneva SE ADR. The current macd is 0.1398553.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Valneva price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Valneva. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Valneva price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Valneva SE ADR Daily Moving Average Convergence/Divergence (MACD) ChartValneva SE ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Valneva SE ADR. The current adx is 12.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Valneva shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Valneva SE ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Valneva SE ADR. The current sar is 8.81722.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Valneva SE ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Valneva SE ADR. The current rsi is 51.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Valneva SE ADR Daily Relative Strength Index (RSI) ChartValneva SE ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Valneva SE ADR. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Valneva price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Valneva SE ADR Daily Stochastic Oscillator ChartValneva SE ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Valneva SE ADR. The current cci is -7.98465367.

Valneva SE ADR Daily Commodity Channel Index (CCI) ChartValneva SE ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Valneva SE ADR. The current cmo is 1.08034394.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Valneva SE ADR Daily Chande Momentum Oscillator (CMO) ChartValneva SE ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Valneva SE ADR. The current willr is -54.68412721.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Valneva is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Valneva SE ADR Daily Williams %R ChartValneva SE ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Valneva SE ADR.

Valneva SE ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Valneva SE ADR. The current atr is 0.41543652.

Valneva SE ADR Daily Average True Range (ATR) ChartValneva SE ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Valneva SE ADR. The current obv is 33,392.

Valneva SE ADR Daily On-Balance Volume (OBV) ChartValneva SE ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Valneva SE ADR. The current mfi is 29.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Valneva SE ADR Daily Money Flow Index (MFI) ChartValneva SE ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Valneva SE ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Valneva SE ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Valneva SE ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.599
Ma 20Greater thanMa 508.076
Ma 50Greater thanMa 1007.714
Ma 100Greater thanMa 2008.842
OpenGreater thanClose7.760
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Valneva with someone you think should read this too:
  • Are you bullish or bearish on Valneva? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Valneva? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Valneva SE ADR

I send you an email if I find something interesting about Valneva SE ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Valneva SE ADR.

Receive notifications about Valneva SE ADR in your mailbox!